Palo Alto, CA 1/16/09—Varian has announced that its expects fiscal year 2009 first-quarter sales, for the quarter ended January 2, to be $205–$210 million, compared to revenues of $237.4 million for the same period a year ago. “Although we entered the first quarter with a strong backlog for these products and saw solid orders during […]
Carlsbad, CA 1/27/09—Life Technologies announced that a jury in the US District Court for the Northern District of California rendered a verdict in favor of the company in its patent infringement dispute with Illumina (see IBO 12/15/08). Life Technologies stated that following a seven-day trial, the jury ruled that Applied Biosystems’ SOLiD technology for DNA […]
Hillsboro, OR 1/5/09—Electron microscopy firm FEI has announced that its gross bookings for the fourth quarter of 2008 totaled more than $170 million, exceeding its October 2008 forecast of $150 million. FEI noted that the gross bookings will be reduced by 5%–8% due to the normal quarterly revaluation of backlog. “Life Science bookings were paced […]
Illkirch Cedex, France 1/5/09—Chiral Technologies Europe, a wholly owned subsidiary of Daicel Chemical Industries that supplies phases, columns and services for enantioselective chromatography, has acquired ChromTech. Based in Congleton, UK, ChromTech provides protein-based columns for reversed-phase HPLC in three phases. “ChromTech’s specialty line of protein-based columns adds a complimentary product range to our Daicel polysaccharide-based […]
Wetzlar, Germany 1/6/09—Microscopy company Leica Microsystems, a Danaher business, has acquired Surgipath Medical Industries for an undisclosed amount. Based in Richmond, Illinois, Surgipath is a provider of consumables and medical device accessories for clinical histology and research laboratories, including processing reagents, storage and specimen transport devices, and cytology accessories and safety products. “The amalgamation of […]
Milford, MA 1/12/09—Waters has announced preliminary sales for the fourth quarter of 2008 of approximately $418 million. This figure is within the range of the company’s revised guidance announced last month of $410-$420 million (see IBO 12/15/08). Waters specifically attributed the reduced sales volume to unfavorable currency translations, slower spending by chemical manufacturers, continued weak […]
San Diego, CA and Oxford, UK 1/11/09—Illumina and Oxford Nanopore Technologies announced a strategic alliance to develop and sell single-molecule DNA sequencing technology. Under a commercialization agreement, Illumina will exclusively market, sell, distribute and service Oxford Nanopore’s BASE Technology products into the research and diagnostic markets. The companies will share profits from the sales. Illumina […]
San Diego, CA 1/9/09 and 1/14/09; Marlborough, MA 1/12/09—Sequenom has announced that it will commence its exchange offer for publicly-held EXACT Sciences, a provider of a noninvasive stool-based DNA screening technology for colorectal cancer, despite a unanimously rejection of its offer by EXACT’s Board. On January 9, Sequenom made public its $41 million all-stock offer […]
Lucerne, Switzerland 12/2/08—Following the sale of its Beverage business and the pending sale of its Real Estate business, Swiss-listed Eichhof Group AG will change its name to Datacolor AG, its Color Management business, early next year and become a dedicated supplier of colorimeters and other color management products (see IBO 8/15/08). The company has also […]
Carlsbad, CA and Abbott Park, IL 12/17/08—Isis Pharmaceuticals announced that Abbott has exercised its option to acquire the remaining equity ownership of Isis’s Ibis Biosciences subsidiary for $175 million and earn-out payments. Bayer currently owns 18.6% of Ibis, for which the company paid $40 million (see IBO 2/15/08, 10/31/08). Ibis’s T5000 Biosensor System identifies and […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
